Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised

Outcome of public consultation on the reflection paper use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes - Summary report of comments received during the public consultation and next steps

Outcome of public consultation on the reflection paper use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes - Summary report of comments received during the public consultation and next steps

Abbreviations used in EMA scientific committees and Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) documents, and in relation to EMA’s regulatory activities

Abbreviations used in EMA scientific committees and Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) documents, and in relation to EMA’s regulatory activities

Paediatric Committee (PDCO): 17-20 June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025 to 20 June 2025

Paediatric Committee (PDCO): 17-20 June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025 to 20 June 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness